Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
3.400
-0.310 (-8.36%)
Mar 31, 2025, 10:57 AM EDT - Market open
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $109.46 million as of March 31, 2025. Its market cap has decreased by -26.20% in one year.
Market Cap
109.46M
Enterprise Value
-39.14M
1-Year Change
-26.20%
Ranking
Category
Stock Price
$3.40
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $109.46M, a decrease of -69.15%. That is a compound annual growth rate of -49.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 119.44M | -17.56% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.35B |
| UnitedHealth Group | 474.11B |
| Johnson & Johnson | 394.44B |
| AbbVie | 361.99B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 228.17B |
| Merck & Co. | 225.93B |
| AstraZeneca | 225.00B |